PURPOSE: Deposition of the macular pigment carotenoids lutein and zeaxanthin in the human retina occurs early in life. In this study, we examined the interrelationships of maternal carotenoid status and newborn infant macular pigment levels and systemic carotenoid status. As a secondary measure, we also evaluated the effects of intrauterine growth restriction (IUGR) on carotenoid status in term newborn infants. METHODS: We measured mother and infant skin carotenoids using resonance Raman spectroscopy (RRS), serum carotenoids by HPLC, and mother breast milk carotenoids by HPLC. We measured infant macular pigment levels using noninvasive blue light reflectometry. RESULTS: We enrolled 30 healthy term infants, their mothers, and 10 IUGR infants and their mothers. A subset of 16 infants was imaged for macular pigment optical density (MPOD). Infant serum zeaxanthin levels correlated with MPOD (r = 0.68, P = 0.007). Mother serum zeaxanthin levels correlated with infant MPOD (r = 0.59, P = 0.032). Infant and mother serum lutein did not correlate with MPOD. Mother-infant correlations were found for total serum carotenoids (r = 0.42, P = 0.020) and skin carotenoids (r = 0.48, P = 0.001). No difference was seen between IUGR infants and controls in total serum or skin carotenoids. Mothers of IUGR infants had lower total serum carotenoids (P = 0.019) and breast milk carotenoids than controls (P = 0.006). CONCLUSIONS: Our findings suggest that maternal zeaxanthin status may play a more important role than lutein status in macular pigment deposition in utero. Controlled trials are needed to determine whether maternal zeaxanthin prenatal supplementation can raise infant macular pigment levels and/or improve ocular function.
PURPOSE: Deposition of the macular pigment carotenoids lutein and zeaxanthin in the human retina occurs early in life. In this study, we examined the interrelationships of maternal carotenoid status and newborn infant macular pigment levels and systemic carotenoid status. As a secondary measure, we also evaluated the effects of intrauterine growth restriction (IUGR) on carotenoid status in term newborn infants. METHODS: We measured mother and infant skin carotenoids using resonance Raman spectroscopy (RRS), serum carotenoids by HPLC, and mother breast milk carotenoids by HPLC. We measured infant macular pigment levels using noninvasive blue light reflectometry. RESULTS: We enrolled 30 healthy term infants, their mothers, and 10 IUGR infants and their mothers. A subset of 16 infants was imaged for macular pigment optical density (MPOD). Infant serum zeaxanthin levels correlated with MPOD (r = 0.68, P = 0.007). Mother serum zeaxanthin levels correlated with infant MPOD (r = 0.59, P = 0.032). Infant and mother serum lutein did not correlate with MPOD. Mother-infant correlations were found for total serum carotenoids (r = 0.42, P = 0.020) and skin carotenoids (r = 0.48, P = 0.001). No difference was seen between IUGR infants and controls in total serum or skin carotenoids. Mothers of IUGR infants had lower total serum carotenoids (P = 0.019) and breast milk carotenoids than controls (P = 0.006). CONCLUSIONS: Our findings suggest that maternal zeaxanthin status may play a more important role than lutein status in macular pigment deposition in utero. Controlled trials are needed to determine whether maternal zeaxanthin prenatal supplementation can raise infant macular pigment levels and/or improve ocular function.
Authors: Paul S Bernstein; Mohsen Sharifzadeh; Aihua Liu; Igor Ermakov; Kelly Nelson; Xiaoming Sheng; Cynthia Panish; Bonnie Carlstrom; Robert O Hoffman; Werner Gellermann Journal: Invest Ophthalmol Vis Sci Date: 2013-06-10 Impact factor: 4.799
Authors: Paul S Bernstein; Faisal Ahmed; Aihua Liu; Susan Allman; Xiaoming Sheng; Mohsen Sharifzadeh; Igor Ermakov; Werner Gellermann Journal: Invest Ophthalmol Vis Sci Date: 2012-09-14 Impact factor: 4.799
Authors: Günther Weigert; Semira Kaya; Berthold Pemp; Stefan Sacu; Michael Lasta; René Marcel Werkmeister; Nikolaus Dragostinoff; Christian Simader; Gerhard Garhöfer; Ursula Schmidt-Erfurth; Leopold Schmetterer Journal: Invest Ophthalmol Vis Sci Date: 2011-10-17 Impact factor: 4.799
Authors: Susan T Mayne; Brenda Cartmel; Stephanie Scarmo; Haiqun Lin; David J Leffell; Erin Welch; Igor Ermakov; Prakash Bhosale; Paul S Bernstein; Werner Gellermann Journal: Am J Clin Nutr Date: 2010-08-04 Impact factor: 7.045
Authors: Stephen Beatty; Usha Chakravarthy; John M Nolan; Katherine A Muldrew; Jayne V Woodside; Frances Denny; Michael R Stevenson Journal: Ophthalmology Date: 2012-12-06 Impact factor: 12.079
Authors: Wei Wang; Sonja L Connor; Elizabeth J Johnson; Michael L Klein; Shannon Hughes; William E Connor Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Marcela D Radtke; Stephanie Jilcott Pitts; Lisa Jahns; Gina C Firnhaber; Brittany M Loofbourrow; April Zeng; Rachel E Scherr Journal: Adv Nutr Date: 2020-09-01 Impact factor: 8.701
Authors: Sarah U Morton; Brian J Leyshon; Eleonora Tamilia; Rutvi Vyas; Michaela Sisitsky; Imran Ladha; John B Lasekan; Matthew J Kuchan; P Ellen Grant; Yangming Ou Journal: Front Psychiatry Date: 2022-06-23 Impact factor: 5.435
Authors: Igor V Ermakov; Maia Ermakova; Mohsen Sharifzadeh; Aruna Gorusupudi; Kelliann Farnsworth; Paul S Bernstein; Jodi Stookey; Jane Evans; Tito Arana; Lisa Tao-Lew; Carly Isman; Anna Clayton; Akira Obana; Leah Whigham; Alisha H Redelfs; Lisa Jahns; Werner Gellermann Journal: Arch Biochem Biophys Date: 2018-03-27 Impact factor: 4.013
Authors: Paul S Bernstein; Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Rajalekshmy Shyam; Bradley S Henriksen; John M Nolan Journal: Prog Retin Eye Res Date: 2015-11-02 Impact factor: 21.198
Authors: Christopher D Conrady; James P Bell; Brian M Besch; Aruna Gorusupudi; Kelliann Farnsworth; Igor Ermakov; Mohsen Sharifzadeh; Maia Ermakova; Werner Gellermann; Paul S Bernstein Journal: Invest Ophthalmol Vis Sci Date: 2017-07-01 Impact factor: 4.799